Skip to main content

NGM Biopharmaceuticals Inc

NGMDelisted Apr 5, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001426332

NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in NGM Biopharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+5 vs. Q2 2022
Shares held
52.8M
+5.42M (+11.4%) vs. Q2 2022
Total value
$689.9M
+$82.6M (+13.6%) vs. Q2 2022
New holders
22
53 more added
Sold out
17
29 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 128 institutions
Q1 2021: 108 institutionsQ2 2021: 107 institutionsQ3 2021: 121 institutionsQ4 2021: 119 institutionsQ1 2022: 114 institutionsQ2 2022: 124 institutionsQ3 2022: 128 institutionsQ4 2022: 125 institutionsQ1 2023: 123 institutionsQ2 2023: 106 institutionsQ3 2023: 95 institutionsQ4 2023: 83 institutionsQ1 2024: 75 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $689.9M
Q1 2021: $1.25BQ2 2021: $849.7MQ3 2021: $951.2MQ4 2021: $833.5MQ1 2022: $732.8MQ2 2022: $607.3MQ3 2022: $689.9MQ4 2022: $248.9MQ1 2023: $200.4MQ2 2023: $124.4MQ3 2023: $50.6MQ4 2023: $35.3MQ1 2024: $55.1MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NGM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202475$55.1M
Q4 202383$35.3M
Q3 202395$50.6M
Q2 2023106$124.4M
Q1 2023123$200.4M
Q4 2022125$248.9M
Q3 2022128$689.9M
Q2 2022124$607.3M
Q1 2022114$732.8M
Q4 2021119$833.5M
Q3 2021121$951.2M
Q2 2021107$849.7M
Q1 2021108$1.25B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding NGM Biopharmaceuticals Inc; share changes are against Q2 2022.

Institutions holding NGM in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC294,135$3.85M0.00%+66,414+29.2%Added
Charles Schwab Investment Management Inc314,559$4.12M0.00%+2,884+0.9%Added
Great Point Partners LLC316,256$4.14M1.00%+316,256New
Jasper Ridge Partners, L.P.318,750$4.17M0.28%00.0%Unchanged
Goldman Sachs Group Inc333,639$4.36M0.00%+161,433+93.7%Added
Northern Trust Corp339,071$4.43M0.00%−2,180−0.6%Reduced
Point72 Asset Management, L.P.362,900$4.75M0.02%−957,762−72.5%Reduced
AXA S.A.405,683$5.31M0.02%+3,240+0.8%Added
Boxer Capital, LLC500,000$6.54M0.37%00.0%Unchanged
JPMorgan Chase & Co533,897$6.98M0.00%−18,644−3.4%Reduced
EcoR1 Capital, LLC541,108$7.08M0.21%00.0%Unchanged
Morgan Stanley547,059$7.16M0.00%−44,165−7.5%Reduced
Geode Capital Management, LLC737,316$9.64M0.00%+8,702+1.2%Added
Nuveen Asset Management, LLC738,810$9.66M0.00%+203,372+38.0%Added
Euclidean Capital LLC746,674$9.77M9.07%00.0%Unchanged
Dimensional Fund Advisors LP787,808$10.3M0.00%+141,090+21.8%Added
Logos Global Management LP850,000$11.1M1.37%+850,000New
State Street Corp855,575$11.2M0.00%+85,133+11.0%Added
Rubric Capital Management LP877,161$11.5M0.58%+79,573+10.0%Added
First Light Asset Management, LLC955,505$12.5M1.26%−180,379−15.9%Reduced
Ponoi Management, LLC1,298,908$17.0M23.20%00.0%Unchanged
Ponoi II Management, LLC1,298,908$17.0M44.41%00.0%Unchanged
StepStone Group LP1,573,357$20.6M2.93%00.0%Unchanged
Avidity Partners Management LP1,798,100$23.5M0.51%+1,798,100New
Vanguard Group Inc3,899,297$51.0M0.00%+496,089+14.6%Added
BlackRock Inc.4,066,577$53.2M0.00%+193,828+5.0%Added
FMR LLC4,324,201$56.6M0.01%+2,263,668+109.9%Added
The Column Group LLC18,136,735$237.2M52.50%00.0%Unchanged
Partners Group Holding AG0$00.00%−177,255−100.0%Sold out
Woodline Partners LP0$00.00%−134,188−100.0%Sold out
Lexington Partners L.P.0$00.00%−110,428−100.0%Sold out
Blackstone Group Inc.0$00.00%−104,432−100.0%Sold out
Baker Bros. Advisors LP0$00.00%−55,294−100.0%Sold out
Washington University0$00.00%−44,314−100.0%Sold out
Hamilton Lane Advisors LLC0$00.00%−37,503−100.0%Sold out
XTX Topco Ltd0$00.00%−34,571−100.0%Sold out
Wellington Management Group LLP0$00.00%−27,005−100.0%Sold out
Engineers Gate Manager LP0$00.00%−27,026−100.0%Sold out
Common Fund for Nonprofit Organizations0$00.00%−17,725−100.0%Sold out
Acadian Asset Management LLC0$00.00%−16,716−100.0%Sold out
ETF Managers Group, LLC0$00.00%−15,271−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−12,492−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−569−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−22−100.0%Sold out
State of Wyoming0$00.00%−25−100.0%Sold out
Exane Derivatives––––Not filed